tiprankstipranks
Humacyte (HUMA)
NASDAQ:HUMA
US Market
HUMA
Humacyte
RESEARCH TOOLSreports
Want to see HUMA full AI Analyst Report?

Humacyte (HUMA) Stock News & Sentiment

1,735 Followers
Humacyte Earnings Call: Clinical Wins vs Cash Burn
Premium
Company Announcements
Humacyte Earnings Call: Clinical Wins vs Cash Burn
19d ago
HUMA
Humacyte Earns Buy Rating as Phase 3 V007 Data Publication Strengthens Regulatory and Commercial Outlook
Premium
Ratings
Humacyte Earns Buy Rating as Phase 3 V007 Data Publication Strengthens Regulatory and Commercial Outlook
24d ago
HUMA
Humacyte Faces Nasdaq Non-Compliance Warning as Share Price Risks Delisting and Future Capital Constraints
Premium
Company Announcements
Humacyte Faces Nasdaq Non-Compliance Warning as Share Price Risks Delisting and Future Capital Constraints
30d ago
HUMA
Humacyte’s Symvess Trauma Study: Real-World Data Push With Investor Upside
Premium
Company Announcements
Humacyte’s Symvess Trauma Study: Real-World Data Push With Investor Upside
1M ago
HUMA
Analyst Reiterates Buy on Humacyte, Maintains $4 Price Target Amid Dialysis Growth and Regulatory Catalysts
Premium
Ratings
Analyst Reiterates Buy on Humacyte, Maintains $4 Price Target Amid Dialysis Growth and Regulatory Catalysts
1M ago
HUMA
HUMA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
HUMA Upcoming Earnings Report: What to Expect?
1M ago
HUMA
Humacyte Receives Nasdaq Notice on Bid Price Noncompliance
Premium
Company Announcements
Humacyte Receives Nasdaq Notice on Bid Price Noncompliance
1M ago
8K
HUMA
More HUMA News >

HUMA News on the Web

Humacyte Earns Buy Rating as Phase 3 V007 Data Publication Strengthens Regulatory and Commercial Outlook
TipRanks News
Bullish
Humacyte Inc (HUMA) (Q2 2026) Earnings Call Highlights: Strong Trial Results and Strategic ...
GuruFocus News
Neutral
Humacyte (HUMA) Q2 2026 Update Highlights Challenges Amid Early Commercial Progress
GuruFocus News
Neutral
BTIG Remains a Buy on Humacyte (HUMA)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Humacyte (HUMA) and Qiagen (QGEN)
TipRanks News
Bullish
Humacyte Announces Underwritten Public Equity Offering to Fund Growth
TipRanks News
Neutral
Humacyte's ATEV Meets Primary Goal In Phase3 V012 Trial For Dialysis Access; Prices $50 Mln Offering
rttnews
Bullish
Humacyte 47.62M share Spot Secondary priced at $1.05
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
HUMA
Sector Average
Media Buzz
This Week1 articles
Weekly Average4.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HUMA’s Media Buzz Sentiment?
1 articles about HUMA were published this week. In an average week, 4.25 articles are published.
    What is HUMA’s weekly average amount of articles?
    In an average week, 4.25 articles about HUMA are published.
      What is HUMA’s News Sentiment?
      100% of articles about HUMA were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        KURAKura Oncology
        AXGNAxoGen
        IRONDisc Medicine
        XERSXeris Pharmaceuticals
        LFSTLifestance Health Group
        Showing the stocks with the most bullish news sentiment over the past week